SI1438960T2 - Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo - Google Patents

Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo

Info

Publication number: SI1438960T2
Authority: SI; Slovenia
Prior art keywords: itraconazole; hydrophilic polymer; dispersed; minutes; composition
Prior art date: 2003-01-14

Application number

SI200330739T

Other languages

English (en)

Other versions

SI1438960T1 (sl

Inventor

Pawan Seth

Original Assignee

Cimex Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-14

Filing date

2003-01-14

Publication date

2013-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1438960(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-01-14 Application filed by Cimex Pharma Ag filed Critical Cimex Pharma Ag

2007-06-30 Publication of SI1438960T1 publication Critical patent/SI1438960T1/sl

2013-04-30 Publication of SI1438960T2 publication Critical patent/SI1438960T2/sl

Links

VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 title abstract 7
229960004130 itraconazole Drugs 0.000 title abstract 7
229920001477 hydrophilic polymer Polymers 0.000 title abstract 3
238000000034 method Methods 0.000 abstract 2
239000004094 surface-active agent Substances 0.000 abstract 2
238000004090 dissolution Methods 0.000 abstract 1
239000012738 dissolution medium Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

SI200330739T 2003-01-14 2003-01-14 Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo SI1438960T2 (sl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03290091A EP1438960B2 (en)	2003-01-14	2003-01-14	Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability

Publications (2)

Publication Number	Publication Date
SI1438960T1 SI1438960T1 (sl)	2007-06-30
SI1438960T2 true SI1438960T2 (sl)	2013-04-30

Family

ID=32524259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200330739T SI1438960T2 (sl)	2003-01-14	2003-01-14	Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo

Country Status (7)

Country	Link
EP (1)	EP1438960B2 (sl)
AT (1)	ATE357234T1 (sl)
DE (1)	DE60312635T3 (sl)
DK (1)	DK1438960T4 (sl)
ES (1)	ES2283724T5 (sl)
PT (1)	PT1438960E (sl)
SI (1)	SI1438960T2 (sl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH30929A (en) *	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
FR2758461A1 (fr) †	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
JP3608800B2 (ja) *	1997-03-26	2005-01-12	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	抗真菌剤およびポリマーでコートされたコアを有するペレット剤
KR19990001564A (ko) *	1997-06-16	1999-01-15	유충식	용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
IL137665A0 (en) *	1998-07-17	2001-10-31	Janssen Pharmaceutica Nv	Pellets having core coated with an antifungal and a polymer
ES2157731B1 (es) *	1998-07-21	2002-05-01	Liconsa Liberacion Controlada	Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
KR100694667B1 (ko) †	1999-12-08	2007-03-14	동아제약주식회사	생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
FR2803748A1 (fr) *	2000-01-14	2001-07-20	Ethypharm Lab Prod Ethiques	Composition d'itraconazole et procede de preparation
US6673373B2 (en) †	2001-02-01	2004-01-06	Carlsbad Technology Inc.	Antifungal formulation and the methods for manufacturing and using the same

2003
- 2003-01-14 SI SI200330739T patent/SI1438960T2/sl unknown
- 2003-01-14 DE DE60312635T patent/DE60312635T3/de not_active Expired - Lifetime
- 2003-01-14 PT PT03290091T patent/PT1438960E/pt unknown
- 2003-01-14 EP EP03290091A patent/EP1438960B2/en not_active Expired - Lifetime
- 2003-01-14 AT AT03290091T patent/ATE357234T1/de active
- 2003-01-14 DK DK03290091.2T patent/DK1438960T4/da active
- 2003-01-14 ES ES03290091T patent/ES2283724T5/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1438960B2 (en)	2012-12-19
SI1438960T1 (sl)	2007-06-30
EP1438960A1 (en)	2004-07-21
DK1438960T3 (da)	2007-07-23
DE60312635T2 (de)	2008-01-03
ATE357234T1 (de)	2007-04-15
ES2283724T5 (es)	2013-04-09
DE60312635D1 (de)	2007-05-03
EP1438960B1 (en)	2007-03-21
DK1438960T4 (da)	2013-03-25
PT1438960E (pt)	2007-06-19
ES2283724T3 (es)	2007-11-01
DE60312635T3 (de)	2013-05-08

Similar Documents

Publication	Publication Date	Title
CA2219475A1 (fr)	1998-07-17	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
ATE442147T1 (de)	2009-09-15	Pharmazeutische zubereitung enthaltend drospirenon
WO2003032953A1 (en)	2003-04-24	Granules containing acid-unstable chemical in large amount
WO2007056284A3 (en)	2007-06-28	Polycationic viscoelastic compositions
IL247486B (en)	2020-02-27	A composition comprising nanoparticles comprising docetaxel, albumin and citrate, uses thereof, a method for it's preparation and a sealed vial and a kit comprising the composition
JP2004517071A5 (sl)	2009-11-05
WO2003002092A3 (en)	2003-04-10	Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
CA2317106A1 (en)	1999-07-08	Method and composition of an oral preparation of itraconazole
DK1531800T3 (da)	2011-07-11	Stealth-lipidnanokapsler, fremgangsmåder til fremstilling deraf som en bærer for aktivt princip(per)
MXPA03011440A (es)	2004-07-01	Composicion de liberacion sostenida y proceso para producirla.
AU2002364625A1 (en)	2003-06-17	Pharmaceutical compositions in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof
AR041324A1 (es)	2005-05-11	Composiciones suavizadoras de papel que contienen compuesto de amonio cuaternario y altos niveles de amina libre y productos de papel tisu suaves que comprenden las composiciones antes mencionadas
EP1110690A3 (en)	2002-03-20	Continuous preparation of heat-vulcanizable silicone compositions
PL362850A1 (pl)	2004-11-02	Miękkie kapsułki żelowe zawierajace ibuprofen
WO2005118166A3 (en)	2006-07-27	Pharmaceutical composition containing irbesartan
JP2003532784A5 (sl)	2008-05-01
EP1813274A4 (en)	2007-11-07	MEDICAL COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR STABILIZING A DIHYDROPYRIDINE COMPOUND IN A MEDICAL COMPOSITION
JP2008538751A5 (sl)	2009-05-21
RU2007137846A (ru)	2009-06-20	Инъецируемые препаративные формы депо и способы обеспечения замедленного высвобождения композиций, состоящих из наночастиц
JP2006512286A5 (sl)	2009-07-09
SI1438960T1 (sl)	2007-06-30	Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo
CA2504873A1 (en)	2004-05-21	Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one
AU2002358819A1 (en)	2003-06-17	Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
JP2006514046A5 (sl)	2007-09-20
WO2005034917A3 (fr)	2005-06-30	Poudre d’eau a base de silice hydrophobe